Skip to main content
SpringerLink
Log in

Overview

  • Chapter
Book cover Helicobacter pylori Infection

Abstract

The clinical expression of chronic Helicobacter pylori (Hp) infection in humans is highly variable. Most infected individuals are asymptomatic. A minority suffers from dyspeptic symptoms and/or duodenal and gastric ulcer disease. Finally, gastric adenocarcinoma and primary gastric lymphoma are increasingly considered as potential end-stage consequences of chronic Hp- associated inflammation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Tytgat GNJ, Noach LA, Rauws EAJ. itHelicobacter pylori infection and duodenal ulcer disease. Gastroenterol Clin N Am. 1993;22:127–139.

    CAS  Google Scholar 

  2. Graham DY. Campylobacter pylori and peptic ulcer disease. Gastroenterology. 1989;96: 615–625.

    PubMed  CAS  Google Scholar 

  3. Dixon MF. Helicobacter pylori and peptic ulceration: histopathological aspects. J Gastroenterol Hepatol. 1991;6:125–130.

    Article  PubMed  CAS  Google Scholar 

  4. Dixon MF, Sobala GM. Gastritis and duodenitis: the histopathological spectrum. Eur J Gastroenterol Hepatol. 1992;4(Suppl 2):S17–S23.

    Google Scholar 

  5. Sobala GM, Axon ATR, Dixon MF. Morphology of chronic gastritis: relationship to age, Helicobacter pylori status and peptic ulcération. Eur J Gastroenterol Hepatol. 1992;4: 825–829.

    Google Scholar 

  6. Axon ATR. Clinical and histological consequences of Helicobacter pylori suppression/eradication. Eur J Gastroenterol Hepatol. 1992;4(Suppl 2):S49–S52.

    Google Scholar 

  7. Sipponen P, Sappälä K, Aarynen M et al. Chronic gastritis and gastroduodenal ulcer: a case control study on risk of coexisting duodenal or gastric ulcer in patients with gastritis. Gut. 1989;30:922–929.

    Article  PubMed  CAS  Google Scholar 

  8. Malfertheiner P, Bode G, Stanesen A et al. Gastric metaplasia and Campylobacter pylori in duodenal ulcer disease: an ultrastructural analysis. Gastroenterol Clin Biol. 1989;13:71B–4B.

    PubMed  CAS  Google Scholar 

  9. Wyatt JI, Rathbone BJ, Sobala G et al. The prevalence and distribution of gastric epithelium in the duodenum and its relationship to Helicobacter pylori and inflammation. J Clin Pathol. 1990;43:981–986.

    Article  PubMed  CAS  Google Scholar 

  10. Noach LA, Rolf TM, Bosma WB et al. Gastric metaplasia and Helicobacter pylori infection. Gut. 1993(Accepted for publication).

    Google Scholar 

  11. Johnston BJ, Reed PI, Alimm H. Campylobacter-like organisms in duodenal and antral endoscopic biopsies: relationship to inflammation. Gut. 1986;27:1132–1137.

    Article  PubMed  CAS  Google Scholar 

  12. Madsen JE, Vetvik K, Aase S. Helicobacter pylori and chronic active inflammation of the duodenum and stomach in duodenal ulcer patients treated with ranitidine, misoprostol, or an acid-neutralizing agent. Scand J Gastroenterol. 1991;26:465–470.

    Article  PubMed  CAS  Google Scholar 

  13. Satoh K, Kimura K, Yoshida Y et al. A topographical relationship between Helicobacter pylori and gastritis: quantitative assessment of Helicobacter pylori in the gastric mucosa. Am J Gastroenterol. 1991;3:285–291.

    Google Scholar 

  14. Cover TL, Dooley CP, Blaser MJ. Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun. 1990;58:603–610.

    PubMed  CAS  Google Scholar 

  15. Cover TL, Puryear W, Perez-Perez GI et al. Effect of urease on HeLa cell vacuolation induced by Helicobacter pylori cytotoxin. Infect Immun. 1991;59:1264–1270.

    PubMed  CAS  Google Scholar 

  16. Figura N, Gulielmetti P, Rossolini A et al. Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only. J Clin Microbiol. 1989;27:225–226.

    PubMed  CAS  Google Scholar 

  17. Leunk RD, Johnson PT, David BC et al. Cytotoxic activity in broth culture filtrates of Campylobacter pylori. J Med Microbiol. 1988;26:414–417.

    Article  Google Scholar 

  18. Tee W, Lambert JR, Pegorer M et al. Cytotoxin production by H. pylori more common in peptic ulcer disease. Gastroenterology. 1993;104:A789.

    Google Scholar 

  19. Crabtree JE, Taylor JD, Wyatt JE et al. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulcération and gastric pathology. Lancet. 1991;338:332–335.

    Article  PubMed  CAS  Google Scholar 

  20. Blaser MJ. Pathogenesis of Helicobacter pylori infection. Postgraduate course, AGA 1993, Boston, pp. 113–117.

    Google Scholar 

  21. Yoshimura HA, Evans DG, Graham DY. H. pylori strains from duodenal ulcer patients differ at the genomic level from those from patients with simple gastritis. Rev Esp Enf Digest. 1990;78(Suppl l):22(O–9).

    Google Scholar 

  22. Höök-Nikanne J, Roine RP, Salmela KS et al. Alcohol dehydrogenase activities of different Helicobacter strains. Gastroenterology. 1993;104:A103.

    Google Scholar 

  23. Jablonowski H, Hengels KJ, Savade C et al. Helicobacter pylori (Hp) from patients with gastritis inhibit acid production more frequently than Hp from duodenal ulcer patients. Gastroenterology. 1993;104:A110.

    Google Scholar 

  24. El-Omar E, Penman I, Dorrian CA et al. Eradicating H. pylori lowers gastrin-mediated acid secretion by 70% in DU patients and by 50% in healthy volunteers. Gastroenterology. 1993;104:A75.

    Google Scholar 

  25. Bayerdörffer E, Kapser G, Pirlet T et al. Ofloxacin in der Therapie Campylobacter pylori — positiver Ulcera Duodeni. Dtsch Med Wochenschr. 1987; 112:1407–1411.

    Article  PubMed  Google Scholar 

  26. Marshall BJ, Goodwin CS, Warren JR et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet. 1988;ii:1437–1442.

    Article  Google Scholar 

  27. Graham DY, Lew GM, Evans DG et al. Effects of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. A randomized controlled trial. Ann Intern Med. 1991;115:266–269.

    PubMed  CAS  Google Scholar 

  28. Mannes GA, Bayerdörffer E, Höchter W et al. Decreased relapse rate after antibacterial treatment of Helicobacter pylori-associated duodenal ulcers. Munich duodenal ulcer trial. Eur J Gastroenterol Hepatol. 1993;5:145–153.

    Article  Google Scholar 

  29. Hentschell E, Brandstätter G, Dragosics B et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med. 1993;312:308–312.

    Article  Google Scholar 

  30. Coghlan JG, Humphries H, Dooley C et al. Campylobacter pylori and recurrence of duodenal ulcers: a 12-month follow-up study. Lancet. 1987;ii:1109–1111.

    Article  Google Scholar 

  31. Lambert JR, Borromeo M, Korman MG et al. Effect of colloidal bismuth (DeNo1) on healing and relapse of duodenal ulcers: role of Campylobacter pyloridis. Gastroenterology. 1987;92:A1489 (abstract).

    Google Scholar 

  32. Marshall BJ, Warren JR, Blincow ED et al. Prospective double blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet. 1988;ii:1437–1442.

    Article  Google Scholar 

  33. Smith AC, Price AB, Borriello O et al. A comparison of ranitidine and tripotassium dicitratobismuthate (TDB) in relapse rates of duodenal ulcer: the role of Campylobacter pylori (c.p.). Gastroenterology. 1988;94:A431 (abstract).

    Google Scholar 

  34. Borody T, Cole P, Noonan S et al. Long-term Campylobacter pylori recurrence post-eradication. Gastroenterology. 1988;94:A43 (abstract).

    Google Scholar 

  35. Borody TJ, Cole P, Noonan S et al. Recurrence of duodenal ulcer and Campylobacter pylori infection after eradication. Med J Aust. 1989;151:431–435.

    PubMed  CAS  Google Scholar 

  36. Rauws EAJ, Tytgat GNJ. Eradication of Helicobacter pylori cures duodenal ulcer disease. Lancet. 1990;i:1233–1235.

    Article  Google Scholar 

  37. Blum AL, Armstrong D, Dammann H et al. The effect of Helicobacter pylori on the healing and relapse of duodenal ulcer. Gastroenterology. 1990;98:A22 (abstract).

    Google Scholar 

  38. George LL, Borody TJ, Andrews P et al. Cure of duodenal ulcer after eradication of Helicobacter pylori. Med J Aust. 1990; 153:145–149.

    PubMed  CAS  Google Scholar 

  39. Grigorjev PYa, Aruin LI, Isakow VA. De-Nol plus Oxacillin vs ranitidine and Oxacillin in HP-positive duodenal ulcers: effects on relapse. Rev Esp Enferm Dig. 1990;78(Suppl 1):129.

    Google Scholar 

  40. Carrick J, Daskalopoulos G, Mitchell H et al. Successful eradication of H. pylori infection prevents recurrence of duodenal ulceration. Rev Esp Enferm Dig. 1990;78(Suppl l):122–123 (abstract).

    Google Scholar 

  41. Patchett S, O’Riordan TO, Leen E et al. A prospective study of Helicobacter pylori eradication in duodenal ulcer. Gastroenterology. 1990;98:A104 (abstract).

    Google Scholar 

  42. Lamouliatte H, Bernard PH, Boulard A et al. Helicobacter pylori eradication prevents duodenal ulcer relapse. Gastroenterology. 1991;100:A104 (abstract).

    Google Scholar 

  43. Graham DY, Lew GM, Evans DG et al. Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. Ann Intern Med. 1991;115:266–269.

    PubMed  CAS  Google Scholar 

  44. Collins RA, Beattie S, O’Morain C. Long-term evaluation of anti-Helicobacter pylori treatment in duodenal ulcer (DU). Monotherapy vs CBS combination therapy. Gastroenterology. 1991;100:A48(abstract).

    Google Scholar 

  45. Logan RPH, Walker MM, Misiewicz JJ et al. Relationship between Helicobacter pylorir recurrence and relapse of duodenal ulcer. Gastroenterology. 1991;100:A112.

    Google Scholar 

  46. Fiocca R, Solcia E, Santoro B. Duodenal ulcer relapse after eradication of Helicobacter pylori (Letter). Lancet. 1991;337:1614.

    Article  PubMed  CAS  Google Scholar 

  47. Sobala GM, Lynch DAF, Gallacher B et al. Eradication of H. pylori prevents duodenal ulcer recurrence. Ir J Med Sci. 1992;161(Suppl 10):89(abstract).

    Google Scholar 

  48. Coelho LGV, Passos MCF, Chausson Y et al. Duodenal ulcer and eradication of Helicobacter pylori in a developing country. An 18-month follow-up study. Scand J Gastroenterol. 1992;27:362–366.

    Article  PubMed  CAS  Google Scholar 

  49. Bayerdörffer E, Mannes GA, Sommer A et al. High dose omeprazole treatment combined with amoxicilin eradicates Helicobacter pylori. Eur J Gastroenterol Hepatol. 1992;4:697–702.

    Google Scholar 

  50. Labenz J, Gyenes E, Rühl GH et al. HP reinfection and clinical course of ulcer disease in the first year after amoxicillin/omeprazole treatment (Abstract). Ir J Med Sci. 1992; 161(Suppl 10):15–16.

    Google Scholar 

  51. Unge P, Gad A, Erikkson K et al. Amoxicillin added to omeprazole prevents relapse in the treatment of duodenal ulcer patients. Eur J Gastroenterol Hepatol. 1993;5:325–331.

    Article  Google Scholar 

  52. Vigneri S, Termini R, Scialabba A et al. One year relapse rate after H. pylori eradication with omeprazole plus antimicrobials. Gastroenterology. 1993;104:A220.

    Google Scholar 

  53. Chung SCS, Sung JY, Hosking SW et al. One week therapy for Helicobacter pylori eradication: follow-up study of a randomized trial at one year after treatment. Gastroenterology. 1993;104:A56.

    Google Scholar 

  54. Balatsos V, Delis V, Skandalis N et al. Triple therapy after duodenal ulcer healing with omeprazole or ranitidine eradicates H. pylori and prevents ulcer relapses: preliminary results of a year follow up study. Gastroenterology. 1993;104:A37.

    Google Scholar 

  55. Logan RPH, Gummett PA, Poison RJ et al. The recurrence of Helicobacter pylori in relation to duodenal ulcer. Rev Esp Enf Digest. 1990;78(Suppl 1):72–73(P-152).

    Google Scholar 

  56. George L, Hyland L, Morgan A et al. Smoking does not contribute to duodenal ulcer relapse after eradication. Gastroenterology. 1990;98:A48.

    Google Scholar 

  57. Tytgat GNJ, Rauws EAJ. Campylobacter pylori and its role in peptic ulcer disease. Gastroenterol Clin N Am. 1990;19:183–196.

    CAS  Google Scholar 

  58. Price AB. The Sydney System: Histological division. J Gastroenterol Hepatol. 1991; 6:209–222.

    Article  PubMed  CAS  Google Scholar 

  59. Craanen ME, Dekker W, Blok P et al. Intestinal metaplasia and Helicobacter pylori: an endoscopie biopsy study of the gastric antrum. Gut. 1992;33:16–20.

    Article  PubMed  CAS  Google Scholar 

  60. Siurala M, Sipponen P, Kekki M. itCampylobacter pylori in a sample of Finnish population: relations to morphology and functions of the gastric mucosa. Gut. 1988;29:909.

    Article  PubMed  CAS  Google Scholar 

  61. Correa P, Haenszel W, Cuello C et al. Gastric precancerous process in a high risk population: cohort follow-up. Cancer Res. 1990;50:4737–4740.

    PubMed  CAS  Google Scholar 

  62. Kawano S, Tsujii M, Fusamoto H et al. Chronic effect of intragastric ammonia on gastric mucosal structures in rats. Dig Dis Sci. 1991;36:33–38.

    Article  PubMed  CAS  Google Scholar 

  63. Marshall BJ. Virulence and pathogenicity of Helicobacter pylori. J Gastroenterol Hepatol. 1991;6:121–124.

    Article  PubMed  CAS  Google Scholar 

  64. Negrini R, Lisato L, Zanella I et al. Helicobacter pylori infection induces antibodies cross-reacting with human gastric mucosa. Gastroenterology. 1991;101:437–445.

    PubMed  CAS  Google Scholar 

  65. Salmela KS, Roine RP, Sipponen P et al. High gastric juice acetaldehyde levels in atrophic gastritis—a possible risk for gastric cancer? Gastroenterology. 1993;104:A446.

    Google Scholar 

  66. Sobala GM, O’Connor HJ, Dewar EP et al. Histological consequences of bile reflux on the gastric mucosa, with special reference to intestinal metaplasia. J Clin Pathol. 1993(In press).

    Google Scholar 

  67. Sobala GM, King RG, Axon ATR et al. Reflux gastritis in the intact stomach. J Clin Pathol. 1990;43:303–306.

    Article  PubMed  CAS  Google Scholar 

  68. Correa P, Cuello C, Fajardo LF et al. Diet and gastric cancer: nutrition survey in a high risk area. J Natl Cancer Inst. 1983;70:673–678.

    PubMed  CAS  Google Scholar 

  69. Tatsuta M, Iishi H, Okuda S. Effect of cigarette smoking on acid-secreting area and intestinal metaplasia in the stomach. Dig Dis Sci. 1988;33:23–29.

    Article  PubMed  CAS  Google Scholar 

  70. Sobala GM, Dixon MF, Pignatelli B et al. Levels of nitrite, nitrate, N-nitrosocompounds, ascorbic acid and total bile acids in gastric juice of patients with and without precancerous conditions of the stomach. Carcinogenesis. 1991;12:193–198.

    Article  PubMed  CAS  Google Scholar 

  71. Correa P, Yardley JH. Grading and classification of chronic gastritis: one American response to the Sydney system. Gastroenterology. 1992;102:355–359.

    PubMed  CAS  Google Scholar 

  72. Neithercut WD, Grieg MA, Hossack M et al. Suicidal destruction of Helicobacter pylori: Metabolic consequence of intracellular accumulation of ammonia. J Clin Pathol. 1991;44:380–384.

    Article  PubMed  CAS  Google Scholar 

  73. Kimura K. Chronological transition of the fundic-pyloric border determined by stepwise biopsy of the lesser and greater curvatures of the stomach. Gastroenterology. 1972;63: 584–592.

    PubMed  CAS  Google Scholar 

  74. Tasuta M, Okuda S. Location, healing and recurrence of gastric ulcers in relation to fundal gastritis. Gastroenterology. 1975;69:897–902.

    Google Scholar 

  75. Oi M, Oshida K, Sugimura S. The location of gastric ulcer. Gastroenterology. 1969;36: 45–56.

    Google Scholar 

  76. Oi M, Sakurai Y. The location of duodenal ulcer. Gastroenterology. 1959;36:60–64.

    PubMed  CAS  Google Scholar 

  77. Dixon MF, Sobala GM, Wyatt JI. Surface epithelial degeneration in H. pylori gastritis; relationship to coexistent peptic ulcer. Irish J Med Sci. 1992 (Suppl 10):13.

    Google Scholar 

  78. Crabtree JE, Figura N, Taylor JD et al. Expression of 120 kilodalton protein and cytotoxicity in Helicobacter pylori. J Clin Pathol. 1992;45:733–734.

    Article  PubMed  CAS  Google Scholar 

  79. Tatsuta M, Ishikawa H, Iishi H et al. Reduction of gastric ulcer recurrence after suppression of Helicobacter pylori by Cefixime. Gut. 1990; 31:973–976.

    Article  PubMed  CAS  Google Scholar 

  80. Seppäla K, Pikkarainen P, Karvonen AL et al. In the Finnish gastric ulcer study group (FGUSG). The role of helicobacter pylori eradication, the gastric ulcer healing and relapse. Gastroenterology. 1992;102:A162.

    Google Scholar 

  81. Graham DY, Lew GM, Klein PD et al. Effect of treatment of Helicobacter pylori infection on the day-term recurrence of gastric or duodenal ulcer. Ann Intern Med. 1992;116:705–708.

    PubMed  CAS  Google Scholar 

  82. Bayerdörffer E, Mannes GA, Höchter W et al. Antibacterial treatment of gastric ulcers — German Gastric Ulcer Study. Gastroenterology. 1993;104:A40.

    Google Scholar 

  83. Tytgat GNJ, Noach LA, Rauws EAJ. Helicobacter pylori. The role of Helicobacter pylori eradication in gastric ulcer healing. Eur J Gastroenterol Hepatol. 1992;4:S7–S15.

    Google Scholar 

  84. Tytgat GNJ, Lee A, Graham DY et al. The role of infectious agents in peptic ulcer disease. Gastroenterol Intern. 1993;6

    Google Scholar 

  85. Fullman H, Van Deventer G, Schneidman D et al. ‘Healed’ duodenal ulcers are histologically ill. Gastroenterology. 1988;88:1390.

    Google Scholar 

  86. Pan S, Liao C-H. The histological maturity of regenerating mucosa of healed duodenal ulcer and ulcer recurrence after treatment with H2-antagonist. Am J Gastroenterol. 1990;85:949–952.

    PubMed  CAS  Google Scholar 

  87. Goodwin CS. Duodenal ulcer, Campylobacter pylori and the ‘leaking roof concept. Lancet. 1988;ii:1467–1469.

    Article  Google Scholar 

Download references

Authors
  1. Guido Tytgat
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael Dixon
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Medicine, St George’s Hospital Medical School, Cranmer Terrace, London, SW17 0RE, UK

    T.C. Northfield (Professor of Gastroenterology), M. Mendall (Lecturer in Gastroenterology) & P. M. Goggin (Research Fellow) (Professor of Gastroenterology),  (Lecturer in Gastroenterology) &  (Research Fellow)

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Tytgat, G., Dixon, M. (1993). Overview. In: Northfield, T., Mendall, M., Goggin, P.M. (eds) Helicobacter pylori Infection. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-2216-0_8

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-2216-0_8

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-4982-5

  • Online ISBN: 978-94-011-2216-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation